Vikram Sarveiya is an experienced professional specializing in the life sciences sector, currently serving as an Executive Consultant at Pharmatech Associates, a USP company, since September 2024, where expertise involves accelerating business growth through the development of product strategies across various modalities. Prior roles include Principal Consultant at Valanza Biopharma since October 2022, and significant positions at Catalent Pharma Solutions that encompass Program and Strategic Alliances for Cell & Gene Therapy and Project and Alliance Management, along with a tenure as Senior Director of Product Development and Manufacturing at Proteostasis Therapeutics, Inc. Vikram's career commenced as a Senior Research Scientist at Pfizer, where leadership and strategic planning were pivotal in drug product development. Academic credentials include a PhD in Pharmaceutical Sciences from the University of Manitoba and an MBA from Rutgers Business School.